NUB1 inhibitors belong to a specific category of chemical compounds that have gained recognition in the field of molecular biology and protein degradation pathways. NUB1, or NEDD8 Ultimate Buster-1, is a protein that plays a critical role in the regulation of protein turnover and degradation. The ubiquitin-proteasome system (UPS) is a cellular mechanism responsible for breaking down and recycling damaged or unnecessary proteins. NUB1 is involved in a specific branch of the UPS known as the NEDD8 pathway, which is responsible for targeting proteins for degradation by attaching the small protein NEDD8 to them. This modification marks proteins for recognition and degradation by the proteasome, ensuring the maintenance of cellular protein quality and homeostasis. NUB1 inhibitors are chemical compounds designed to interact with NUB1, potentially modulating its role in the NEDD8 pathway and influencing protein degradation processes.
The mechanism of action of NUB1 inhibitors typically involves their binding to specific regions or domains within the NUB1 protein. This interaction can lead to changes in NUB1's ability to recognize and target proteins for NEDD8 modification, potentially affecting the efficiency and specificity of protein degradation through the NEDD8 pathway. Consequently, NUB1 inhibitors may have implications for various cellular processes that rely on proper protein turnover, including the regulation of protein abundance, clearance of misfolded proteins, and control of signaling pathways. The study of NUB1 inhibitors is instrumental in advancing our understanding of protein degradation pathways, offering insights into the molecular mechanisms that govern the maintenance of protein quality and cellular homeostasis. Additionally, it contributes to the broader field of cell biology and molecular biology research, providing valuable tools for investigating the roles of NUB1 in various cellular contexts and its impact on protein turnover and cellular function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, thereby potentially decreasing NUB1 mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation, which could nonspecifically affect NUB1 protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to FKBP12 and inhibits mTOR, which could lead to altered protein synthesis, potentially affecting NUB1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into RNA and DNA and may alter gene expression, potentially affecting NUB1 mRNA levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase that could change chromatin structure and thereby influence NUB1 gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could lead to feedback effects on protein expression, potentially altering NUB1 levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to inhibit lysosomal function and autophagy, which might influence cellular pathways regulating NUB1 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that might affect protein turnover and indirectly influence NUB1 protein levels. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor that can affect transcription of certain genes, potentially altering NUB1 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression by activating nuclear receptors, which could lead to changes in NUB1 mRNA levels. | ||||||